Lack of Association Between the CYP1A1 Ile462Val Polymorphism and Endometrial Cancer Risk: a Meta-analysis |
Wang, Xi-Wen
(Bao'an Maternal and Child Health Hospital)
Zhong, Tian-Yu (Clinical laboratory,First Affiliated Hospital of Gannan Medical University) Xiong, Yun-Hui (Fuyong peoples hospital) Lin, Hai-Bo (Bao'an Maternal and Child Health Hospital) Liu, Qing-Yi (Bao'an Maternal and Child Health Hospital) |
1 | Ashton KA, Proietto A, Otton G, et al (2010). Polymorphisms in genes of the steroid hormone biosynthesis and metabolism pathways and endometrial cancer risk. Cancer Epidemiol, 34, 328-37. DOI |
2 | Auersperg N, Edeson MI, Mok SC, et al (1998) The biology of ovarian cancer. Semin Oncol, 25, 281-304. |
3 | Barrena Medel NI, Bansal S, Miller DS, et al (2009). Pharmacotherapy of endometrial cancer. Expert Opin Pharmacother, 10, 1939-51. DOI |
4 | Cochran WG (1954). The combination of estimates from different experiments. Biometrics, 10, 101-29. DOI |
5 | Cosma G, Crofts F, Taioli E, et al (1993). Relationship between genotype and function of the human CYP1A1 gene. J Toxicol Environ Health, 40, 309-16. DOI |
6 | DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. DOI |
7 | Doherty JA, Weiss NS, Freeman RJ, et al (2005). Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer.. Cancer Epidemiol Biomarkers Prev, 14, 357-66. DOI |
8 | Drakoulis N, Cascorbi I, Brockmoller J, et al (1994) Polymorphism in the human CYP 1 A 1gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3'- flanking region. Clin Invest, 72, 240-8. |
9 | Egger M, Davey Smith G. Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. DOI |
10 | Elwood JM, Cole P, Rothman KJ, et al (1977). Epidemiology of endometrial cancer. J Natl Cancer Inst, 59, 1055-60. DOI |
11 | Esinler I, Aktasy D, Alikasifogluy M, et al (2006). CYP1A1 gene polymorphism and risk of endometrial hyperplasia and endometrial carcinoma. Int J Gynecol Cancer, 16, 1407-11. DOI |
12 | Esteller M, Garcia A, Martinez-Palones JM, et al (1997). Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis, 18, 2307-11. DOI ScienceOn |
13 | Herrington CS (2001). What we could do now: molecular pathology of gynaecological cancer. Mol Pathol, 54, 222-4. DOI |
14 | Esteller M, Garcia A, Martinez-Palones JM, et al (1997). Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci. Br J Cancer, 75, 1385-8. DOI |
15 | Fader AN, Arriba LN, Frasure HE, et al (2009). Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol, 114, 121-7 DOI |
16 | Hayashi S, Watanabe J, Nakachi K, et al (1991). Genetic linkage of lung cancer-associated Msp1 polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1. J Biochem, 110, 407-11. DOI |
17 | Higgins JP, Thompson SE (2002). Quantifying heterogeneity in a metaanalysis. Stat Med, 21, 1539-58. DOI ScienceOn |
18 | Hirata H, Hinoda Y, Okayama N, et al (2008). CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility. Cancer, 112, 1964-73. DOI |
19 | Kawajiri K, Nakachi K, Imai K, et al (1993). The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol, 14, 77-7. DOI ScienceOn |
20 | Key TJ, Pike MC (1988). The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer, 57, 205-12. DOI |
21 | Kiyohara C, Hirohata T, Inutsuka S (1996). The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Jpn J Cancer Res, 87, 18-24. DOI |
22 | McGrath M, Hankinson SE, De Vivo I (2007). Cytochrome P450 1A1, cigarette smoking, and risk of endometrial cancer (United States). Cancer Causes Control, 18, 1123-30. DOI |
23 | La Vecchia C, Decarli A, Fasoli M, et al (1986). Nutrition and diet in the etiology of endometrial cancer. Cancer, 57, 1248-53. DOI |
24 | Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48. |
25 | Martucci CP, Fishman J (1993). P450 enzymes of estrogen metabolism. Pharmacol Ther, 57, 237-57. DOI |
26 | Petersen DD, McKinney CE, Ikeya K, et al (1991). Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet, 48, 720-5. |
27 | Rebbeck TR, Troxel AB, Wang Y, et al (2006). Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. J Natl Cancer Inst, 98, 1311-20. DOI |
28 | Schwarz D, Kisselev P, Schunck WH, et al (2000). Allelic variants of human cytochrome P450 1A1 (CYP1A1): effect of T461N and I462V substitutions on steroid hydroxylase specificity. Pharmacogenetics, 10, 519-30. DOI |
29 | Seremak-Mrozikiewicz A, Drews K, Semczuk A, et al (2005). CYP1A1 alleles in female genital cancers in the Polish population. Eur J Obstet Gynecol Reprod Biol, 118, 246-50. DOI |
30 | Sugawara T, Nomura E, Sagawa T, et al (2003). CYP1A1 polymorphism and risk of gynecological malignancy in Japan. Int J Gynecol Cancer, 13, 785-90. DOI |
31 | Taioli E, Crofts F, Trachman J, et al (1995) Radical differences in CYP1A1 genotype and function. Toxicol Lett, 77, 357-62. DOI |
32 | Zintzaras E, Chatzoulis DZ, Karabatsas CH, et al (2005). The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a metaanalysis. J Hum Genet, 50, 267-75. DOI |
33 | Zhang ZY, Fasco MJ, Huang L, et al (1996). Characterization of purified human recombinant cytochrome P4501A1-Ile462 and -Val462: assessment of a role for the rare allele in carcinogenesis. Cancer Res, 56, 3926-33. |